Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Edison

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Frontiers in Aging Neuroscience|January 22, 2025
Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infectionGabriela Gonzalez Aleman, George D Vavougios, Carmela Tartaglia, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Nature Reviews. Immunology|December 9, 2024
Neuroinflammation in Alzheimer diseaseMichael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global ConsortiumGabriel A de Erausquin, Heather Snyder, Traolach S Brugha, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Trials|July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Trials|April 5, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Frontiers in Aging Neuroscience|January 22, 2025
Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infectionGabriela Gonzalez Aleman, George D Vavougios, Carmela Tartaglia, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Nature Reviews. Immunology|December 9, 2024
Neuroinflammation in Alzheimer diseaseMichael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global ConsortiumGabriel A de Erausquin, Heather Snyder, Traolach S Brugha, et al.
Pageof 16